Revenue from Contracts with Customers (Tables)

3 Months Ended

Mar. 26, 2021

Disaggregation of Revenue [Line Items]

The following table reflects activity in the Company's sales reserve accounts:


	Rebates and Chargebacks		Product Returns		Other Sales Deductions		Total
Balance as of December 27, 2019	$	295.8	$	28.4	$	13.2	$	337.4
Provisions	457.8		3.8		13.7		475.3
Payments or credits	(498.8)		(6.1)		(15.9)		(520.8)
Balance as of March 27, 2020	$	254.8	$	26.1	$	11.0	$	291.9

Balance as of December 25, 2020	$	196.5	$	26.6	$	12.3	$	235.4
Provisions (1)	488.0		25.7		13.0		526.7


Payments or credits	(442.9)		(10.0)		(14.9)		(467.8)
Balance as of March 26, 2021	$	241.6	$	42.3	$	10.4	$	294.3

(1)Provisions for returns increased by $21.9 million driven by the Specialty Brands segment primarily related to a discrete return of product sold during the three months ended March 26, 2021.

Disaggregation of Revenue

Product sales transferred to customers at a point in time and over time were as follows:


	Three Months Ended
		March 26, 2021		March 27, 2020
Product sales transferred at a point in time		75.7	%	78.5	%
Product sales transferred over time		24.3		21.5

The associated royalty revenue recognized was as follows:


	Three Months Ended
		March 26, 2021		March 27, 2020
Royalty revenue		$	35.4	$	15.6

Contract with Customer, Timing of Satisfaction of Performance Obligation and Payment

The following table includes estimated revenue from contracts extending greater than one year for certain of the Company's hospital products that are expected to be recognized in the future related to performance obligations that were unsatisfied or partially unsatisfied as of March 26, 2021:


Remainder of Fiscal 2021	$	70.9
Fiscal 2022	41.0
Fiscal 2023	9.9
Thereafter	0.3